Peter Salob, MD
Orthopaedic Surgery · Englewood, NJNPI 1881646040
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,189 of the $1,792 with a category attached, or 66.4%. 16 manufacturers reported payments, led by Seapearl East, Inc at 39.0% of the total. Reporting peaked in 2019 at $911 and has fallen 70.5% since, to $269 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NJ, where the typical reported total is $2,530.
Across 41 payments — averaging $43.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seapearl East, Inc$699
- Kerecis Limited$267
- Johnson & Johnson$261
- Ferring Pharmaceuticals Inc.$85
- Pacira Therapeutics, Inc.$73
- Zimmer Biomet$62
- plus $346 from 10 others
What the payments were for
- Food & beverage$1,18966%
- Education$60334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seapearl East, Inc | 4 | $699 |
| Kerecis Limited | 3 | $267 |
| Johnson & Johnson | 6 | $261 |
| Ferring Pharmaceuticals Inc. | 5 | $85 |
| Pacira Therapeutics, Inc. | 5 | $73 |
| Zimmer Biomet | 2 | $62 |
| Guard Medical Inc. | 1 | $62 |
| Integra Lifesciences Corporation | 2 | $61 |
| Ossur Americas, Inc. | 3 | $60 |
| Fidia Pharma USA Inc. | 2 | $31 |
| Amgen | 2 | $28 |
| Axogen | 2 | $26 |
| ERMI LLC | 1 | $24 |
| Endo USA, Inc. | 1 | $21 |
| Bioventus LLC | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,792 in reported general payments places this provider in the 45th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 112 | $305 |
| Nabumetone | 20 | $258 |
| Diclofenac Sodium | 24 | $219 |
| Celecoxib | 13 | $209 |
| Ibuprofen | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Englewood
- Asit ShahEnglewood$775K
- Michael KellyHackensack$9.7M
- Mark HartzbandParamus$9.4M
- Randal BetzLawrenceville$3M
- Luke AustinSewell$2.9M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Harlan LevineMontvale$1.5M
- Jeffrey AbramsPrinceton$1.5M
- Gregg KleinParamus$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.